MedPath

ABBVIE

ABBVIE logo
🇺🇸United States
Ownership
-
Established
2013-01-01
Employees
-
Market Cap
$346B
Website
http://www.abbvie.com

Real World Evidence of the Effectiveness of Paritaprevir/r - Ombitasvir, ± Dasabuvir, ± Ribavirin in Patients With Chronic Hepatitis C - An Observational Study in Hungary

Completed
Conditions
Chronic Hepatitis C
First Posted Date
2015-12-22
Last Posted Date
2019-07-26
Lead Sponsor
AbbVie
Target Recruit Count
244
Registration Number
NCT02636608

The Efficacy and Safety of ABT-493/ABT-530 in Adults With Chronic Hepatitis C Virus Genotype 4, 5, or 6 Infection (ENDURANCE-4)

Phase 3
Completed
Conditions
Hepatitis C Virus
Interventions
First Posted Date
2015-12-22
Last Posted Date
2021-07-13
Lead Sponsor
AbbVie
Target Recruit Count
121
Registration Number
NCT02636595

Long-term Safety and Efficacy Study of Adalimumab in Pediatric Subjects With Ulcerative Colitis

Phase 3
Completed
Conditions
Ulcerative Colitis
Interventions
First Posted Date
2015-12-16
Last Posted Date
2025-05-01
Lead Sponsor
AbbVie
Target Recruit Count
59
Registration Number
NCT02632175
Locations
🇺🇸

Arnold Palmer Hospital /ID# 147295, Orlando, Florida, United States

🇺🇸

MNGI Digestive Health, P. A. /ID# 147294, Minneapolis, Minnesota, United States

🇺🇸

Mayo Clinic - Rochester /ID# 147304, Rochester, Minnesota, United States

and more 13 locations

A Study Comparing Upadacitinib (ABT-494) to Placebo and to Adalimumab in Adults With Rheumatoid Arthritis Who Are on a Stable Dose of Methotrexate and Who Have an Inadequate Response to Methotrexate

Phase 3
Active, not recruiting
Conditions
Rheumatoid Arthritis
Interventions
First Posted Date
2015-12-14
Last Posted Date
2024-06-18
Lead Sponsor
AbbVie
Target Recruit Count
1629
Registration Number
NCT02629159
Locations
🇺🇸

Precision Research Org, LLC /ID# 143092, Miami Lakes, Florida, United States

🇺🇸

DM Clinical Research /ID# 151357, Tomball, Texas, United States

🇿🇦

Arthritis Clinical Research Tr /ID# 144874, Cape Town, Western Cape, South Africa

and more 367 locations

Drug Use-results Survey in Patients Infected With Hepatitis C Virus Genotype 1

Completed
Conditions
Chronic Hepatitis C Virus
First Posted Date
2015-12-14
Last Posted Date
2020-02-24
Lead Sponsor
AbbVie
Target Recruit Count
3043
Registration Number
NCT02629172
Locations
🇯🇵

Mori Clinic /ID# 157489, Osaka, Japan

🇯🇵

Aichi Medical University Hosp /ID# 152220, Nagakute, Aichi, Japan

🇯🇵

Nagoya City University Hospital /ID# 153642, Nagoya-shi, Aichi, Japan

and more 385 locations

Real-World Outcome of Rheumatoid Arthritis Patients in Korea on Adalimumab

Completed
Conditions
Rheumatoid Arthritis
First Posted Date
2015-12-11
Last Posted Date
2019-03-22
Lead Sponsor
AbbVie
Target Recruit Count
91
Registration Number
NCT02627924

The Effectiveness of Paritaprevir/Ritonavir - Ombitasvir, ± Dasabuvir, ± Ribavirin in France

Completed
Conditions
Chronic Hepatitis C
First Posted Date
2015-12-02
Last Posted Date
2019-06-17
Lead Sponsor
AbbVie
Target Recruit Count
735
Registration Number
NCT02618928
Locations
🇫🇷

Hopital Pitie Salpetriere /ID# 145566, Paris, France

🇫🇷

CHR Orleans - Hopital de la Source /ID# 147250, Orleans CEDEX 2, Centre-Val De Loire, France

🇫🇷

Hopital Universitaire Purpan /ID# 150141, Toulouse, Haute-Garonne, France

and more 67 locations

Real World Evidence of the Effectiveness of Paritaprevir/r - Ombitasvir, ± Dasabuvir, ± Ribavirin in Patients With Chronic Hepatitis C - An Observational Study in Germany (LIFE-C)

Completed
Conditions
Chronic Hepatitis C
First Posted Date
2015-11-26
Last Posted Date
2019-10-07
Lead Sponsor
AbbVie
Target Recruit Count
472
Registration Number
NCT02615145

Real-World Outcome of Adalimumab on Rheumatoid Arthritis Patients in Taiwan

Completed
Conditions
Rheumatoid Arthritis
First Posted Date
2015-11-26
Last Posted Date
2019-03-14
Lead Sponsor
AbbVie
Target Recruit Count
100
Registration Number
NCT02616380

Observational Study Evaluating Long-Term Effectiveness of Duodopa/Duopa in Patients With Advanced Parkinson's Disease

Completed
Conditions
Advanced Parkinson's Disease
First Posted Date
2015-11-23
Last Posted Date
2021-12-15
Lead Sponsor
AbbVie
Target Recruit Count
213
Registration Number
NCT02611713
Locations
🇺🇸

University of Pennsylvania /ID# 161135, Philadelphia, Pennsylvania, United States

🇷🇴

Spitatlul Clinic Colentina /ID# 144447, Bucharest, Romania

🇺🇸

Mercy St. Mary's Health Center /ID# 144418, Grand Rapids, Michigan, United States

and more 51 locations
© Copyright 2025. All Rights Reserved by MedPath